| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 07/16/2013 | CA2535029C Pharmaceutical compositions and methods for accelerating wound healing |
| 07/16/2013 | CA2526007C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 07/10/2013 | EP2612853A1 c-Met modulators and methods of use |
| 07/10/2013 | EP2612629A1 Compositions for transdermal oxybutynin therapy |
| 07/10/2013 | CN1809340B Pharmaceutical products |
| 07/10/2013 | CN103191410A Treatment of T-cell mediated diseases |
| 07/10/2013 | CN103191409A Treatment of T-cell mediated diseases |
| 07/10/2013 | CN101838261B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 07/09/2013 | US8481518 Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| 07/09/2013 | US8481488 Compositions and methods for reducing the risk of preterm labor |
| 07/09/2013 | US8481055 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | US8481000 Thickened beverages for dysphagia |
| 07/09/2013 | CA2640994C Enamel matrix protein composition for preventing or treating infection |
| 07/09/2013 | CA2537290C Delivery of physiological agents with in-situ gels comprising anionic polysaccharides |
| 07/09/2013 | CA2533314C Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 07/09/2013 | CA2511530C Night-time oral insulin therapy |
| 07/04/2013 | US20130172394 Use of pramipexole to treat amyotrophic lateral sclerosis |
| 07/04/2013 | US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 07/03/2013 | EP2609919A2 c-Met modulators and methods of use |
| 07/03/2013 | CN101502648B Vaccine |
| 07/03/2013 | CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 07/02/2013 | US8476298 c-Met modulators and method of use |
| 07/02/2013 | US8475808 Immunogenic reagents from west nile virus |
| 07/02/2013 | CA2535483C Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 06/27/2013 | US20130165377 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 06/27/2013 | US20130164363 Antimicrobial flush solutions |
| 06/26/2013 | EP2606865A1 Compositions for transdermal oxybutynin therapy |
| 06/25/2013 | US8470865 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 06/25/2013 | US8470367 Oral drug delivery system |
| 06/25/2013 | US8470364 Once daily formulations of tetracyclines |
| 06/25/2013 | US8470298 Method of preparing a medium with bubbles formed therein for contemporaneous injection |
| 06/25/2013 | CA2521885C Once daily formulations of tetracyclines |
| 06/20/2013 | US20130158092 New Oral Formulation |
| 06/20/2013 | US20130156749 Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 06/20/2013 | US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases |
| 06/19/2013 | CN101316616B Method of dynamic nuclear polarisation (DNP) using a trityl radical and a paramagnetic metal ion |
| 06/19/2013 | CN101305990B Use of EDG receptor binding agents in cancer |
| 06/18/2013 | US8466175 Form of S-omeprazole |
| 06/18/2013 | US8466143 Azepine derivatives as pharmaceutical agents |
| 06/18/2013 | US8466139 Formulation |
| 06/18/2013 | US8466120 Oligomeric compounds and compositions for use in modulation of pri-miRNAs |
| 06/18/2013 | CA2534895C Hemostatic compositions containing sterile thrombin |
| 06/18/2013 | CA2532800C Anaplastic lymphoma kinase modulators and methods of use |
| 06/18/2013 | CA2524047C Immunosuppressant compounds and compositions |
| 06/18/2013 | CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/18/2013 | CA2422002C Vaccine |
| 06/13/2013 | US20130149334 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/12/2013 | EP2601953A1 Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 06/12/2013 | CN1942588B Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/12/2013 | CN103145844A A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 06/12/2013 | CN103145715A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
| 06/12/2013 | CN103142599A Treatment of T-cell mediated diseases |
| 06/11/2013 | US8461104 Surface protection of exposed biological tissues |
| 06/11/2013 | US8460665 Compositions and methods including a recombinant human MAB that promotes CNS remyelination |
| 06/11/2013 | US8460637 Reconstitutable microsphere compositions useful as ultrasonic contrast agents |
| 06/11/2013 | CA2538857C Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives |
| 06/06/2013 | US20130144048 Therapeutic compositions |
| 06/06/2013 | US20130143949 G-CSF Transferrin Fusion Proteins |
| 06/05/2013 | EP2599502A2 Method for preparation of site-specific protein conjugates |
| 06/04/2013 | US8455652 Inhibitors for the soluble epoxide hydrolase |
| 06/04/2013 | US8455490 Facially amphiphilic polymers and oligomers and uses thereof |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 06/04/2013 | US8454939 Low dose pharmaceutical powders for inhalation |
| 06/04/2013 | CA2545660C Heterocyclic inhibitors of mek and methods of use thereof |
| 06/04/2013 | CA2545659C Bicyclic inhibitors of mek |
| 06/04/2013 | CA2541709C Anti-pecam therapy for metastasis suppression |
| 05/29/2013 | CN1964960B Recovery of phytonutrients from oils |
| 05/29/2013 | CN1813061B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 05/29/2013 | CN103122031A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450364 Use of equol for treating androgen mediated diseases |
| 05/28/2013 | US8450062 SOCS-3 promoter methylation in cancer |
| 05/28/2013 | US8449913 Methods of administering a dermatological agent to a subject |
| 05/28/2013 | US8449870 Stable cosmetic emulsion with polyamide gelling agent |
| 05/28/2013 | CA2550298C Reduction of toxicity of multi-targeting antifolates |
| 05/28/2013 | CA2540692C Oligonucleotide synthesis with alternative solvents |
| 05/28/2013 | CA2536175C Pharmaceutical compositions and method of using levodopa and carbidopa |
| 05/28/2013 | CA2535338C Substituted 1h-imidazo[4,5-c]pyridin-4-amines,1h-imidazo[4,5-c]quinolin -4-amines and 1h-imidazo[4,5-c]naphthyridin-4-amines as immune response modifiers |
| 05/28/2013 | CA2522006C Systems and methods for respiratory event detection |
| 05/28/2013 | CA2515033C Clk-peptide and slk-peptide |
| 05/28/2013 | CA2508830C Antimicrobial suture coating |
| 05/23/2013 | US20130129696 Human Stem Cell Materials and Methods |
| 05/21/2013 | US8445665 Therapeutic compositions |
| 05/21/2013 | US8445646 Therapeutic use of anti-CS1 antibodies |
| 05/21/2013 | US8445636 Antimicrobial and anticancer lipopeptides |
| 05/21/2013 | CA2522614C Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 05/21/2013 | CA2349203C Dispersible phospholipid stabilized microparticles |
| 05/16/2013 | US20130123359 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| 05/16/2013 | US20130122083 Dna vaccines encoding heat shock proteins |
| 05/14/2013 | CA2516399C Pharmaceutical compositions of safingol and methods of using the same |
| 05/14/2013 | CA2514720C Coated particles and pharmaceutical dosage forms |
| 05/14/2013 | CA2506696C Method for the prevention of malaria |
| 05/09/2013 | US20130116175 Reversible pegylated drugs |
| 05/09/2013 | US20130115268 Methods of Administering a Dermatological Agent to a Subject |
| 05/08/2013 | EP2589335A2 Systems and methods for respiratory event dedection |
| 05/07/2013 | US8436010 Treatment of solid tumors with rapamycin derivatives |
| 05/07/2013 | CA2531566C Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
| 05/02/2013 | US20130109702 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 05/01/2013 | EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor |